Size matters: Bristol-Myers to acquire Celgene in one of the largest pharma deal in history for $74bn

Bristol-Myers Squibb Company (NYSE: BMY) – market cap as of 10/2/2019: $81.98bn Celgene Corporation (NASDAQ: CELG) – market cap as of 10/2/2019: $61.56bn Introduction On the 3rd of January 2019, Bristol-Myers Squibb Company (NYSE: BMY) announced the acquisition of Celgene Corporation (NASDAQ: CELG) in a cash and stock transaction with Read more…